DIE WELT, the Goethe University Frankfurt am Main and ServiceValue GmbH appoint the Ulm-based health specialist Beurer as "Service Champion 2019" in the field of electrical appliances for health.
Rimidi, a cloud-based software platform that enables personalized management of chronic cardiometabolic conditions across populations, today announced a new disease ‘view’ within its platform – obesity. Obesity becomes the fifth disease state being managed within the software, along with type 2 diabetes, heart failure, nonalcoholic fatty liver disease and cardiovascular disease.
#rpm
A study published in the New England Journal of Medicine found that Type 1 diabetes patients using a closed-loop system spent a higher percentage of time in their target glucose range than their peers using a sensor-augmented pump.
#closed loop
MyWay Digital Health has been ranked as 7th in BusinessCloud’s Scotland Top Tech for 2019. The list highlights Scotland’s most exciting technology companies, with the final ranking decided by a combination of a judging panel and a public vote.
BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its fourth fiscal quarter and full fiscal year 2019 earnings conference call on Tuesday, November 5, 2019, at 8:00 a.m. (ET).
Cecelia Health, a leading technology-enabled chronic disease management company based in New York City, has hired former President and CEO of MetroPlus Health Plan, Arnold Saperstein MD, FACP, as Chief Medical Officer. Saperstein began his career in managed care in 1992 and joined MetroPlus Health Plan in 1995 initially as Chief Medical Officer and then as President and CEO from 2006 until 2019. MetroPlus Health Plan, a wholly-owned subsidiary of the New York City Health + Hospitals is a managed care organization that, under Saperstein’s leadership grew from 40,000 members to over 500,000 members with an estimated 32,000 participating providers.
Brigther, developer of Actiste digital diabetes management solutions and devices, has acquired all shares in the digital elderly care and remote monitoring company Camanio Care AB, in accordance with the previously announced share transfer agreement between Brighter and Camanio Care AB (publ) ("Camanio Care") on September 29, 2019. The Camanio operations will be completely independent in the form of a separate subsidiary with its own management and board, while Brighter will continue to focus on selling the Actiste service and developing new application areas.
#product & service
#rpm
Third-quarter worldwide sales of $8.1 billion increased 5.5 percent on a reported basis and 7.6 percent on an organic basis. In Diabetes Care, sales increased 29.6 percent on a reported basis and 33.1 percent on an organic basis in the third quarter. Sales growth in the quarter was led by FreeStyle Libre, Abbott's revolutionary continuous glucose monitoring system, with worldwide sales of $496 million, an increase of 63.1 percent on a reported basis and 67.6 percent on an organic basis versus the prior year.
Medtronic plc (NYSE:MDT) today announced that Sean Salmon, previously Senior Vice President (SVP) and President, Coronary and Structural Heart (CSH) within the Cardiac and Vascular Group of Medtronic, has been named Executive Vice President (EVP) and Group President of Medtronic Diabetes, effective today. Salmon will serve on the company’s Executive Committee and succeeds Hooman Hakami, who is leaving Medtronic.
Dr. Hirsch has many years of experience utilizing clinical psychology, data analytics and educational design to create innovative healthcare technology that helps people lead healthier, more fulfilling lives. Prior to joining Dario, Dr. Hirsch served as Chief Clinical Officer at a behavioral health company called myStrength, helping lead the company from inception through its acquisition by Livongo Health, Inc. in the first quarter of 2019. She holds a Ph.D. in Clinical Psychology from the University of Massachusetts.